Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer

Acta Oncologica

Volumn 47, Issue 8, 2008, Pages 1546-1550

  Abdul, Mansoor ^a   McCray, Shawntae D ^a   Hoosein, Naseema M ^a  

^a CLAFLIN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ARECAIDINE; BACLOFEN; BICUCULLINE; CHLORIDE ION; DIHYDROERGOTOXINE; PICROTOXIN; SACLOFEN;

ACINAR CELL; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN LNCAP; CHLORIDE TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BINDING; EPITHELIUM; GLEASON SCORE; HUMAN; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; STAINING; STROMA;

BICUCULLINE; CELL PROLIFERATION; COLONIC NEOPLASMS; DIHYDROERGOTOXINE; GABA AGONISTS; GABA ANTAGONISTS; HUMANS; ISONICOTINIC ACIDS; MALE; PICROTOXIN; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, GABA-A; RECEPTORS, GABA-B; TUMOR CELLS, CULTURED;

EID: 54349088292     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860801961265     Document Type: Article

References (25)

1. Owens DF, Kriegstein AR. Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 2002;3:715-27.
2. Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 2002;213:1-47.
3. Gilon P, Remacle C, de Varebeke J, Pauwels G, Hoet JJ. GABA content and localization of high-affinity GABA uptake during the development of the rat pancreas. Cell Mol Biol 1987;33:573-85.
4. Azuma H, Inamoto T, Sakamoto T, Kiyama S, Ubai T, Shinohara Y, et al. Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. Cancer Res 2003;63:8090-6.
5. Ippolito JE, Merritt ME, Backhed F, Moulder KL, Mennerick S, Manchester JK, et al. Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proc Natl Acad Sci USA 2006;103:12505-10.
6. Ben-Ari Y. Excitatory actions of GABA during development: The nature of the nurture. Nat Rev Neurosci 2002;3:728-39.
7. Stein V, Nicoll RA. GABA generates excitement. Neuron 2003;37:375-8.
8. Abdul M, Hoosein NM. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 2002;186:99-106.
9. Diaz M, Abdul M, Hoosein NM. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2. The Prostate (Suppl) 1998;8:32-6.
10. Tvrdeic A, Pericic D. Dihydroergotoxine modulation of the GABAA receptor-associated Cl - ionophore in mouse brain. Eur J Pharmacol 1992;221:139-43.
11. Tvrdeic A, Pericic D. Dihydrogenated ergot compounds bind with high affinity to GABAA receptor-associated Cl - ionophore. Eur J Pharmacol 1991;202:109-11.
12. Napoleone P, Bronzett E, Cavallotti C, Amenta F. Predominant epithelial localization of type A gamma-aminobutyric acid receptor sites within rat seminal vesicles and prostate glands. Pharmacology 1990;41:49-56.
13. Opolski A, Mazurkiewicz M, Wietrzyk J, Kleinrok Z, Radzikowski C. The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J Exp Clin Cancer Res 2000;19:383-90.
14. Matuszek M, Jesipowicz M, Kleinrok Z. GABA content and GAD activity in gastriccancer. Med Sci Monit 2001;7:377-81.
15. Kleinrok Z, Matuszek M, Jesipowicz J, Matuszek B, Opolski A, Radzikowski C. GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J Physiol Pharmacol 1998;49:303-10.
16. Maemura K, Yamauchi H, Hayasaki H, Kanbara K, Tamayama T, Hirata I, et al. Gamma-amino-butyric acid immunoreactivity in intramucosal colonic tumors. J Gastroenterol Hepatol 2003;18:1089-94.
17. Johnson K, Haun RS. The gamma-aminobutyric acid receptor π subunit is overexpressed in pancreatic adenocarcinomas. J Pancreas 2005;6:136-42.
18. Hevers W, Luddens H. The diversity of GABA A receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 1998;18:35-86.
19. Bowery NG, Smart TG. GABA and glycine as neurotransmitters: A brief history. Brit J Pharmacol 2006;147:S109-19.
20. Cascio M. Modulating inhibitory ligand-gated ion channels. AAPS J 2006;8:E353-61.
21. Boue-Garbot E, Taupignon A, Tramu G, Garret M. Molecular and electrophysiological evidence for a GABAc receptor in thyrotropin-secreting cells. Endocrinology 2000;14:1627-32.
22. Burt DR, Kamatchi GL. GABAa receptor subtypes: From pharmacology to molecular biology. FASEB J 1991;5:2916-23.
23. Hosie AM, Dunne EL, Harvey RJ, Smart TG. Zinc-mediated inhibition of GABAa receptors: Discrete binding sites underlie subtype specificity. Nat Neurosci 2003;6:362-9.
24. Hedblom E, Kirkness EF. A novel class of GABAa receptor subunit in tissues of the reproductive system. J Biol Chem 1997;272:15346-50.
25. Santhakumar V, Hanchar HJ, Wallner M, Olsen RW, Otis TS. Contributions of the GABAa receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene. J Neurosci 2006;26:3357-64.